Grupo de Investigación en Enfermedades Digestivas
- Número de publicaciones
- 102
Publicaciones
-
Casanova, MJ; Chaparro, M; Minguez, M; Ricart, E; Taxonera, C; Garcia-Lopez, S; Guardiola, J; Lopez-San Roman, A; Iglesias, E; Beltran, B; Sicilia, B; Vera, MI; Hinojosa, J; Riestra, S; Domènech E; Calvet, X; Perez-Calle, JL; Martin-Arranz, MD; Aldeguer, X; Rivero, M; Monfort, D; Barrio, J; Esteve, M; Marquez, L; Lorente, R; Garcia-Planella, E; de Castro, L; Bermejo, F; Merino, O; Rodriguez-Perez, A; Martinez-Montiel, P; Van Domselaar, M; Alcain, G; Dominguez-Cajal, M; Muñoz C; Gomollon, F; Fernandez-Salazar, L; Garcia-Sepulcre, MF; Rodriguez-Lago, I; Gutierrez, A; Arguelles-Arias, F; Rodriguez, C; Rodriguez, GE; Bujanda, L; Llao, J; Varela, P; Ramos, L; Huguet, JM; Almela, P; Romero, P; Navarro-Llavat, M; Abad, A; Ramirez-de la Piscina, P; Lucendo, AJ; Sese, E; Madrigal, RE; Charro, M; Garcia-Herola, A; Pajares, R; Khorrami, S; Gisbert, JP
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Inflammatory Bowel Diseases 26 606-616. .
-
Bernet Sánchez A; Bellés Bellés A; Aramburu Arnuelos J; Jover Sanz A; Sesé Abizanda E; Vallverdú Vidal M; García González M
Entamoeba histolytica liver abscess case: could stool PCR avoid it?
DIAGNOSIS 7 69-73. .
-
Revuelto Artigas T; Zaragoza Velasco N; Gómez Arbones X; Vidal Ballester T; Piñol Felis C; Reñe Espinet JM; Betriu Bars A
Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis
REVISTA CLINICA ESPANOLA 219 293-302. .
-
Revuelto Artigas T; Betriu Bars À; Zaragoza Velasco N; Gómez Arbones X; Vidal Ballester T; Piñol Felis C; Reñé Espinet JM
Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis c virus
GASTROENTEROLOGIA Y HEPATOLOGIA 42 362-371. .
-
Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J
beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Lancet 393 1597-1608. .
-
Bars-Cortina, D; Riera-Escamilla, A; Gou, G; Piñol-Felis C; Motilva, MJ
Design, optimization and validation of genes commonly used in expression studies on DMH/AOM rat colon carcinogenesis model
PeerJ 7 -. .
-
Ballester-Clau, R; Torres Vicente, G; Volta-Pardo, T; Lopez-Barroso, L; Cucala-Ramos, M; Reñé-Espinet JM; Planella de Rubinat, Montse
Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 31 116-122. .
-
Dosil, MA; Navaridas, R; Mirantes, C; Tarragona, J; Eritja, N; Felip, I; Urdanibia, I; Megino, C; Domingo, M; Santacana, M; Gatius, S; Piñol C; Barcelo, C; Maiques, O; Macia, A; Velasco, A; Vaquero, M; Matias-Guiu, X; Dolcet, X
Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis
JOURNAL OF PATHOLOGY 247 72-85. .
-
Ardevol, A; Ibañez-Sanz G; Profitos, J; Aracil, C; Castellvi, JM; Alvarado, E; Cachero, A; Horta, D; Miñana J; Gomez-Pastrana, B; Pavel, O; Dueñas E; Casas, M; Planella, M; Castellote, J; Villanueva, C
Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies
Hepatology 67 1458-1471. .
-
Catalan, U; de las Hazas, MCL; Pinol, C; Rubio, L; Motilva, MJ; Fernandez-Castillejo, S; Sola, R
Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway
JOURNAL OF FUNCTIONAL FOODS 40 280-291. .
-
López de Las Hazas MC; Piñol C; Macia, A; Motilva, MJ
Hydroxytyrosol and the Colonic Metabolites Derived from Virgin Olive Oil Intake Induce Cell Cycle Arrest and Apoptosis in Colon Cancer Cells
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 65 6467-6476. .
-
Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M
Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers
MEDICINA CLINICA 149 61-71. .